Logo image of AMC.DE

ALBEMARLE CORP (AMC.DE) Stock Fundamental Analysis

FRA:AMC - Deutsche Boerse Ag - US0126531013 - Common Stock - Currency: EUR

68.22  -0.31 (-0.45%)

Fundamental Rating

3

Overall AMC gets a fundamental rating of 3 out of 10. We evaluated AMC against 69 industry peers in the Chemicals industry. The financial health of AMC is average, but there are quite some concerns on its profitability. AMC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

AMC had negative earnings in the past year.
In the past year AMC had a positive cash flow from operations.
AMC had positive earnings in 4 of the past 5 years.
Each year in the past 5 years AMC had a positive operating cash flow.
AMC.DE Yearly Net Income VS EBIT VS OCF VS FCFAMC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

AMC's Return On Assets of -6.34% is on the low side compared to the rest of the industry. AMC is outperformed by 72.46% of its industry peers.
With a Return On Equity value of -10.70%, AMC is not doing good in the industry: 71.01% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROIC N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
AMC.DE Yearly ROA, ROE, ROICAMC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

The Gross Margin of AMC (7.76%) is worse than 84.06% of its industry peers.
AMC's Gross Margin has declined in the last couple of years.
AMC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
AMC.DE Yearly Profit, Operating, Gross MarginsAMC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

AMC does not have a ROIC to compare to the WACC, probably because it is not profitable.
AMC has about the same amout of shares outstanding than it did 1 year ago.
AMC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AMC has an improved debt to assets ratio.
AMC.DE Yearly Shares OutstandingAMC.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AMC.DE Yearly Total Debt VS Total AssetsAMC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

AMC has an Altman-Z score of 1.66. This is a bad value and indicates that AMC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.66, AMC is not doing good in the industry: 68.12% of the companies in the same industry are doing better.
AMC has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
AMC has a better Debt to Equity ratio (0.31) than 65.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.66
ROIC/WACCN/A
WACC8.16%
AMC.DE Yearly LT Debt VS Equity VS FCFAMC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

AMC has a Current Ratio of 2.31. This indicates that AMC is financially healthy and has no problem in meeting its short term obligations.
AMC has a better Current ratio (2.31) than 75.36% of its industry peers.
AMC has a Quick Ratio of 1.47. This is a normal value and indicates that AMC is financially healthy and should not expect problems in meeting its short term obligations.
AMC's Quick ratio of 1.47 is fine compared to the rest of the industry. AMC outperforms 73.91% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.47
AMC.DE Yearly Current Assets VS Current LiabilitesAMC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for AMC have decreased strongly by -155.42% in the last year.
AMC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.05%.
AMC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.42% yearly.
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%

3.2 Future

AMC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 63.97% yearly.
Based on estimates for the next years, AMC will show a quite strong growth in Revenue. The Revenue will grow by 13.04% on average per year.
EPS Next Y33.75%
EPS Next 2Y52.84%
EPS Next 3Y58.22%
EPS Next 5Y63.97%
Revenue Next Year-11.82%
Revenue Next 2Y-2.15%
Revenue Next 3Y3.93%
Revenue Next 5Y13.04%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AMC.DE Yearly Revenue VS EstimatesAMC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
AMC.DE Yearly EPS VS EstimatesAMC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMC. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 101.60 indicates a quite expensive valuation of AMC.
Based on the Price/Forward Earnings ratio, AMC is valued a bit more expensive than 69.57% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.78. AMC is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 101.6
AMC.DE Price Earnings VS Forward Price EarningsAMC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80 100

4.2 Price Multiples

68.12% of the companies in the same industry are cheaper than AMC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.03
AMC.DE Per share dataAMC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as AMC's earnings are expected to grow with 58.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.84%
EPS Next 3Y58.22%

More info and screens

4

5. Dividend

5.1 Amount

AMC has a Yearly Dividend Yield of 2.31%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.05, AMC pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.39, AMC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.31%

5.2 History

The dividend of AMC is nicely growing with an annual growth rate of 13.04%!
Dividend Growth(5Y)13.04%
Div Incr Years3
Div Non Decr Years3
AMC.DE Yearly Dividends per shareAMC.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

AMC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of AMC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-32.53%
EPS Next 2Y52.84%
EPS Next 3Y58.22%
AMC.DE Yearly Income VS Free CF VS DividendAMC.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

More info and screens

ALBEMARLE CORP

FRA:AMC (8/13/2025, 7:00:00 PM)

68.22

-0.31 (-0.45%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners98.79%
Inst Owner ChangeN/A
Ins Owners0.36%
Ins Owner ChangeN/A
Market Cap8.03B
Analysts67.5
Price Target70.89 (3.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.31%
Yearly Dividend2.28
Dividend Growth(5Y)13.04%
DP-32.53%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)91.46%
Min EPS beat(2)69.72%
Max EPS beat(2)113.21%
EPS beat(4)2
Avg EPS beat(4)-30.22%
Min EPS beat(4)-249.28%
Max EPS beat(4)113.21%
EPS beat(8)3
Avg EPS beat(8)-20.6%
EPS beat(12)7
Avg EPS beat(12)-3.87%
EPS beat(16)11
Avg EPS beat(16)2.43%
Revenue beat(2)1
Avg Revenue beat(2)0.26%
Min Revenue beat(2)-7.88%
Max Revenue beat(2)8.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.61%
Min Revenue beat(4)-8.69%
Max Revenue beat(4)8.39%
Revenue beat(8)4
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.94%
Revenue beat(16)6
Avg Revenue beat(16)-0.69%
PT rev (1m)1.71%
PT rev (3m)-4.97%
EPS NQ rev (1m)-85.33%
EPS NQ rev (3m)-1965.2%
EPS NY rev (1m)0%
EPS NY rev (3m)-15.49%
Revenue NQ rev (1m)-0.55%
Revenue NQ rev (3m)-2.52%
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-1.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 101.6
P/S 1.88
P/FCF N/A
P/OCF 12.06
P/B 0.92
P/tB 1.13
EV/EBITDA 26.03
EPS(TTM)-2.31
EYN/A
EPS(NY)0.67
Fwd EY0.98%
FCF(TTM)-1.32
FCFYN/A
OCF(TTM)5.66
OCFY8.29%
SpS36.24
BVpS74.32
TBVpS60.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.76%
FCFM N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 7.37
Cap/Depr 146.27%
Cap/Sales 19.25%
Interest Coverage N/A
Cash Conversion 180.86%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 1.47
Altman-Z 1.66
F-Score4
WACC8.16%
ROIC/WACCN/A
Cap/Depr(3y)401.9%
Cap/Depr(5y)389.55%
Cap/Sales(3y)23.64%
Cap/Sales(5y)25.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y33.75%
EPS Next 2Y52.84%
EPS Next 3Y58.22%
EPS Next 5Y63.97%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%
Revenue Next Year-11.82%
Revenue Next 2Y-2.15%
Revenue Next 3Y3.93%
Revenue Next 5Y13.04%
EBIT growth 1Y80.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.47%
EBIT Next 3Y43.09%
EBIT Next 5Y38.95%
FCF growth 1Y-118.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.5%
OCF growth 3Y26.81%
OCF growth 5Y-0.49%